Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Trek Therapeutics in-licenses rights to Medivir's MIV-802

Aug. 17, 2016

Sanofi announces public dengue immunization program in Brazil with Dengvaxia

Aug. 16, 2016

Novadigm Therapeutics discloses positive data from phase IIa trial

Aug. 16, 2016

Novel DNA vaccines provide enhanced protection from Pseudomonas aeruginosa in mice

Aug. 16, 2016

Wockhardt reports beta-lactamase inhibitors

Aug. 12, 2016

Targeting the parasite proteosome shows promise for the treatment of kinetoplastid infections

Aug. 12, 2016

HHS awards funding to advance Hologic's Procleix Zika Virus Assay

Aug. 11, 2016

New international collaborations to tackle antimicrobial resistance

Aug. 11, 2016

Roche patent reveals anti-HBV agents

Aug. 11, 2016

Medical Research Council awards funding for development of new tests for bacterial infections

Aug. 10, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.